LIF and neoplasm: Treatment with LIF-neutralizing antibody at 10 mg/kg/mouse before injection of human pancreatic cancer cells, followed by treatment twice a week, successfully prevented tumor establishment in a pancreatic xenograft model (Fig. 4c).